Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.290
-0.020 (-0.87%)
Nov 21, 2024, 4:00 PM EST - Market closed
Protara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | - | -40.42 | -65.95 | -47.25 | -33.98 | -7.83 | |
| Depreciation & Amortization | - | 0.34 | 0.25 | 0.12 | 0.2 | 0.02 | |
| Asset Writedown & Restructuring Costs | - | - | 29.52 | - | - | - | |
| Loss (Gain) From Sale of Investments | - | -0.44 | 1.14 | 1.74 | - | - | |
| Stock-Based Compensation | - | 6.09 | 6.69 | 10.36 | 9.75 | 0.42 | |
| Other Operating Activities | - | 1.01 | 1.37 | 1.05 | - | - | |
| Change in Accounts Payable | - | 0.85 | 0.63 | 0.04 | 0.2 | 0.37 | |
| Change in Other Net Operating Assets | - | -4.99 | -0.09 | -0.56 | 0.43 | 2.01 | |
| Operating Cash Flow | - | -37.56 | -26.46 | -34.5 | -23.41 | -5.01 | |
| Capital Expenditures | - | -0.05 | -0.12 | -0.6 | -0.88 | -0.48 | |
| Cash Acquisitions | - | - | - | - | 3.72 | - | |
| Investment in Securities | - | 53.15 | 15.07 | -97.6 | - | - | |
| Investing Cash Flow | - | 53.11 | 14.95 | -98.19 | 2.84 | -0.48 | |
| Short-Term Debt Repaid | - | - | - | - | -1.67 | - | |
| Total Debt Repaid | - | - | - | - | -1.67 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | -1.67 | - | |
| Issuance of Common Stock | - | - | - | - | 86.51 | 0.5 | |
| Repurchase of Common Stock | - | -0.09 | -0.09 | -0.23 | - | - | |
| Other Financing Activities | - | - | - | - | 12.95 | - | |
| Financing Cash Flow | - | -0.09 | -0.09 | -0.23 | 189.4 | 0.5 | |
| Net Cash Flow | - | 15.46 | -11.6 | -132.92 | 168.83 | -4.99 | |
| Free Cash Flow | - | -37.6 | -26.58 | -35.1 | -24.29 | -5.49 | |
| Free Cash Flow Per Share | - | -3.32 | -2.36 | -3.12 | -3.36 | -2.13 | |
| Cash Interest Paid | - | - | - | - | 0.03 | - | |
| Levered Free Cash Flow | - | -21.88 | -15.16 | -20.23 | -13.65 | -2.55 | |
| Unlevered Free Cash Flow | - | -21.88 | -15.16 | -20.23 | -13.63 | -2.55 | |
| Change in Net Working Capital | -1.95 | 1.01 | -1.49 | 0.43 | 1.16 | -2.38 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.